Archive for the ‘Laguna Pharmaceuticals’ Category

Laguna Pharmaceuticals

February 24th, 2015 | Posted in 2015, Laguna Pharmaceuticals

Laguna Pharmaceuticals, La Jolla, completed a $30 million Series B financing. The biopharmaceutical company previously known as ChanRx, and recently relocated from Cleveland, will use the fund to progress Phase 3 clinical development of its lead compound, vanoxerine, a therapeutic drug candidate for the treatment of atrial fibrillation and atrial flutter.